Mark S. Schroeder, EVP, President Diagnostics & COO at LABCORP HOLDINGS INC. (LH), sold 7,475 shares at $231.67 ($1.7M) on 2025-03-28, disclosed to the SEC on 2025-03-31.
Scheduled sale ($1.7M) by EVP, President Diagnostics & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $231.67 | 2,205 | $511K | 29.5% |
| 2 | $231.67 | 2,635 | $610K | 35.3% |
| 3 | $231.67 | 2,635 | $610K | 35.3% |
| Total | $231.67 avg | 7,475 | $1.7M | 100% |
| Filing → |
| LH | SELL | 2024-03-11 | $2.2M | — | Filing → |
| LH | SELL | 2023-05-22 | $325K | — | Filing → |
| LH | SELL | 2023-04-03 | $1.8M | — | Filing → |